A detailed history of Tower Research Capital LLC (Trc) transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 340 shares of MDGL stock, worth $106,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares
340
Previous 2,655 87.19%
Holding current value
$106,080
Previous $743,000 90.31%
% of portfolio
0.0%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$212.22 - $292.96 $491,289 - $678,202
-2,315 Reduced 87.19%
340 $72,000
Q2 2024

Aug 13, 2024

BUY
$193.33 - $291.99 $336,394 - $508,062
1,740 Added 190.16%
2,655 $743,000
Q1 2024

May 15, 2024

SELL
$171.37 - $283.23 $239,403 - $395,672
-1,397 Reduced 60.42%
915 $244,000
Q4 2023

Feb 13, 2024

BUY
$120.4 - $237.13 $30,340 - $59,756
252 Added 12.23%
2,312 $534,000
Q3 2023

Nov 14, 2023

BUY
$146.04 - $225.78 $53,596 - $82,861
367 Added 21.68%
2,060 $300,000
Q2 2023

Aug 14, 2023

BUY
$203.88 - $312.0 $256,888 - $393,120
1,260 Added 290.99%
1,693 $391,000
Q1 2023

May 09, 2023

SELL
$231.06 - $307.08 $649,047 - $862,587
-2,809 Reduced 86.64%
433 $105,000
Q4 2022

Feb 10, 2023

SELL
$58.39 - $296.54 $149,069 - $757,066
-2,553 Reduced 44.06%
3,242 $941,000
Q3 2022

Nov 10, 2022

BUY
$60.57 - $79.51 $200,607 - $263,337
3,312 Added 133.39%
5,795 $377,000
Q2 2022

Aug 15, 2022

BUY
$58.04 - $100.2 $83,693 - $144,488
1,442 Added 138.52%
2,483 $177,000
Q1 2022

May 12, 2022

SELL
$55.89 - $101.89 $56,001 - $102,093
-1,002 Reduced 49.05%
1,041 $102,000
Q4 2021

Feb 14, 2022

BUY
$72.34 - $95.09 $56,352 - $74,075
779 Added 61.63%
2,043 $173,000
Q3 2021

Nov 15, 2021

SELL
$78.35 - $105.02 $81,405 - $109,115
-1,039 Reduced 45.12%
1,264 $101,000
Q2 2021

Aug 16, 2021

BUY
$97.2 - $137.59 $181,278 - $256,605
1,865 Added 425.8%
2,303 $224,000
Q1 2021

May 17, 2021

BUY
$108.54 - $125.2 $43,307 - $49,954
399 Added 1023.08%
438 $51,000
Q4 2020

Feb 16, 2021

SELL
$110.06 - $133.7 $43,473 - $52,811
-395 Reduced 91.01%
39 $4,000
Q3 2020

Nov 16, 2020

SELL
$99.78 - $124.21 $141,088 - $175,632
-1,414 Reduced 76.52%
434 $51,000
Q2 2020

Aug 13, 2020

BUY
$60.13 - $125.71 $53,515 - $111,881
890 Added 92.9%
1,848 $209,000
Q1 2020

May 15, 2020

BUY
$66.76 - $93.49 $52,873 - $74,044
792 Added 477.11%
958 $64,000
Q4 2019

Feb 07, 2020

SELL
$84.28 - $118.5 $26,463 - $37,209
-314 Reduced 65.42%
166 $15,000
Q3 2019

Nov 05, 2019

BUY
$84.4 - $106.53 $40,512 - $51,134
480 New
480 $41,000
Q3 2018

Nov 13, 2018

SELL
$207.3 - $300.31 $32,960 - $47,749
-159 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$101.55 - $313.9 $14,318 - $44,259
141 Added 783.33%
159 $44,000
Q1 2018

May 15, 2018

BUY
$93.35 - $149.04 $1,680 - $2,682
18 New
18 $2,000
Q4 2017

Feb 09, 2018

SELL
$39.35 - $97.37 $8,853 - $21,908
-225 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$15.48 - $46.19 $3,483 - $10,392
225
225 $10,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.34B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.